Athyrium Opportunities IV Acquisition 2 LP - Insider Trading & Ownership

Location
505 Fifth Avenue, Floor 18, New York, NY
Summary
The estimated value of insider holdings of Athyrium Opportunities IV Acquisition 2 LP is at least $201K dollars as of August 12, 2022. Athyrium Opportunities IV Acquisition 2 LP is the 10%+ Owner of RVL Pharmaceuticals plc and owns shares of RVL Pharmaceuticals plc stock worth about $201K.
Signature
/s/ Athyrium Opportunities IV Acquisition 2 LP, by Athyrium Opportunities Associates IV LP, its General Partner, by Athyrium Opportunities Associates IV GP LLC, its General Partner, by Andrew Hyman, Senior Vice President, Secretary
All Insider Reports
All Insider Reports

Ownership of Athyrium Opportunities IV Acquisition 2 LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RVLP RVL Pharmaceuticals plc 10%+ Owner $201K Aug 8, 2022

There are no insider transactions reported by Athyrium Opportunities IV Acquisition 2 LP